Shortly thereafter, on August 5, 2025, Innovent Biologics announced FDA IND clearance for IBI3032, its novel oral small-molecule GLP-1 receptor agonist
Bacteriostatic water contains 0.9% benzyl alcohol as a preservative and is commonly referenced in laboratory settings for repeated-access reconstitution workflows
doi:10.1016/S2213-8587(21)00174-1 American Diabetes Association Professional Practice Committee
doi: 10.1007/s11356-019-04585-5 166 CharronMJWilliamsLSekiYDuXQChaurasiaBSaghatelianAet al
However, when the breastmilk and infant were analyzed, neither showed any botulinum toxin at all, and the infant was safely breastfed
[DOI] [PubMed] [Google Scholar] 83.Trolliet MR, Rudd MA, Loscalzo J